Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-12-001317

Director acquired 17,577 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2011-12-30 Grant or award +17,577 260,077 D
Loading xslF345X03/doc4.xml…